New research shows that a drug for osteoporosis is expected to be used to treat hair loss, such as baldness

Previous studies have found that cyclosporine-A, an immunosuppressive drug used to treat transplant rejection and autoimmune diseases (http://www.chemdrug.com/), can promote hair growth, but it cannot be directly used to treat hair loss due to serious side effects Recently, a new study published in the Journal of science public library biology shows that a drug for osteoporosis (http://www.chemdrug.com/) is expected to be used to treat hair loss such as baldness Experiments conducted by Nathan Hawke Shaw from the center for dermatology research at University of Manchester, UK, showed that the drug "WAY-316606" for treating osteoporosis has the effect of stimulating scalp hair follicle development The Hawkshaw team analyzed the whole gene expression of the scalp hair follicles treated with cyclosporine-A (http://www.chemdrug.com/sell/76/), and found that the drug inhibited the expression of secretory curl associated protein 1, which can inhibit the development of many tissues including hair follicles The researchers finally found that the drug "way-316606" and "cyclosporin-A", which are used to treat osteoporosis, have the same mechanism and can both antagonize "secretory curl associated protein 1", thus removing the "molecular gate" of human body inhibiting hair growth The researchers said the external use of the drug is expected to have the same biological effect as cyclosporine-A, but no side effects Further clinical trials (http://www.chemdrug.com/sell/24/) are needed to determine whether the drug or similar compound is safe and effective for the treatment of hair loss, the researchers said.